Morten Hasselstrøm Jensen

Learn More
We investigated whether physiological data can be used for predicting chronic obstructive pulmonary disease (COPD) exacerbations. Home measurements from 57 patients were analysed, during which 10 exacerbations occurred in nine patients. A total of 273 different features were evaluated for their discrimination abilities between periods with and without(More)
OBJECTIVE The aim was to evaluate the usability of the design of the telehealth system, named Telekit, developed for the Danish TeleCare North Trial, early into the design process in order to assess potential problems and limitations which could hinder its successful implementation. METHODS Five experts, including one who pilot-tested the Telekit system,(More)
BACKGROUND Chronic obstructive pulmonary disease (COPD) affects millions of people worldwide. A complication of COPD is exacerbations that result in increased utilization of healthcare services, readmissions to the hospital, and a decline in health-related quality of life. Home telehealth has been shown both to improve health-related quality of life and to(More)
BACKGROUND Hypoglycemia is a potentially fatal condition. Continuous glucose monitoring (CGM) has the potential to detect hypoglycemia in real time and thereby reduce time in hypoglycemia and avoid any further decline in blood glucose level. However, CGM is inaccurate and shows a substantial number of cases in which the hypoglycemic event is not detected by(More)
BACKGROUND The purpose of this study was to evaluate the performance of a new continuous glucose monitoring (CGM) calibration algorithm and to compare it with the Guardian(®) REAL-Time (RT) (Medtronic Diabetes, Northridge, CA) calibration algorithm in hypoglycemia. SUBJECTS AND METHODS CGM data were obtained from 10 type 1 diabetes patients undergoing(More)
BACKGROUND An important task in diabetes management is detection of hypoglycemia. Professional continuous glucose monitoring (CGM), which produces a glucose reading every 5 min, is a powerful tool for retrospective identification of unrecognized hypoglycemia. Unfortunately, CGM devices tend to be inaccurate, especially in the hypoglycemic range, which(More)
BACKGROUND People with type 1 diabetes (T1D) are unable to produce insulin and thus rely on exogenous supply to lower their blood glucose. Studies have shown that intensive insulin therapy reduces the risk of late-diabetic complications by lowering average blood glucose. However, the therapy leads to increased incidence of hypoglycemia. Although inaccurate,(More)
Continuous glucose monitoring (CGM) is a new technology with the potential to detect hypoglycemia in people with Type 1 diabetes. However, the inaccuracy of the device in the hypoglycemic range is unfortunately too large. The aim of this study was to develop an information and communication technology system for improving hypoglycemia detection in CGM. The(More)
  • 1